Net Medical Xpress Solutions, Inc. appointed Clara Jee, an experienced clinical trial nurse practitioner, to Head Variant Detection Programs that will be required for all clinical trial candidates.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.016 USD | +6.33% |
|
0.00% | +100.00% |
2022 | Net Medical Xpress Solutions, Inc. Appoints Clara Jee as Head of Variant Detection Program | CI |
2017 | Net Medical Xpress Solutions, Inc. Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
+100.00% | 601K | |
+19.61% | 3,343B | |
+17.60% | 92.78B | |
+16.90% | 87.29B | |
+38.85% | 53.09B | |
-21.89% | 48.57B | |
+35.78% | 47.79B | |
+86.22% | 43.32B | |
-31.70% | 42.29B | |
-1.70% | 27.69B |
- Stock Market
- Equities
- NMXS Stock
- News Net Medical Xpress Solutions, Inc.
- Net Medical Xpress Solutions, Inc. Appoints Clara Jee as Head of Variant Detection Program